Journal article
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI
Abstract
The long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in patients undergoing early percutaneous coronary intervention (PCI) after fibrinolytic therapy is unknown. From May 2014 to August 2016, 212 patients undergoing PCI within 24 h of Tenecteplase (TNK), Aspirin, and Clopidogrel for ST-elevated myocardial infarction (STEMI) were randomized at four Canadian sites to receive additional Clopidogrel or Ticagrelor initiated prior …
Authors
Yang A; Pon Q; Lavoie A; Crawford JJ; Harenberg S; Zimmermann RH; Booker J; Kelly S; Lavi S; Cantor WJ
Journal
Journal of Thrombosis and Thrombolysis, Vol. 45, No. 2, pp. 225–233
Publisher
Springer Nature
Publication Date
February 2018
DOI
10.1007/s11239-017-1581-2
ISSN
0929-5305